Form 4 for INVE INVE Technologies, Inc.
Accepted 2023-04-25 00:00:00 ET · period of report 2023-04-24 · accession 0001781002-23-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-04-25 | 2023-04-24 | INVE | Bleichroeder LP | 10% | X - OptEx | $3.50 | +275.0K | 2.88M | +11% | +$962.5K |
| DI | 2023-04-25 | 2023-04-24 | INVE | Bleichroeder LP | 10% | X - OptEx | — | -275.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-24 | X | A | 275,000 | $3.50 | 2,884,495 | I See footnote | — | — | (F2) This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. |
| 2 | Derivative | Warrant to Purchase Common Stock | 2023-04-24 | X | D | 275,000 | — | 0 | I See footnote | $3.50 · — to — | 275,000 Common Stock | (F1) On May 5, 2020, 21 April Fund, Ltd., 21 April Fund, LP and Identiv, Inc. (the "Issuer") entered into an agreement under which 21 April Fund, Ltd. purchased from the Issuer a secured subordinated promissory note in a principal amount of $2,800,000 and a warrant to purchase 192,500 shares of the Issuer's common stock at a per share exercise price of $3.50, and 21 April Fund LP purchased from the Issuer a secured subordinated promissory note in a principal amount of $1,200,000 and a warrant to purchase 82,500 shares of the Issuer's common stock at a per share exercise price of $3.50. (F2) This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. |